Kodiak Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2016
Selling, General & Admin	60.75	71.02	73.79	49.71	28.62	Upgrade
Research & Development	126.1	206.3	267.59	217.34	107.39	Upgrade
Operating Expenses	186.85	277.32	341.38	267.05	136.01	Upgrade
Operating Income	-186.85	-277.32	-341.38	-267.05	-136.01	Upgrade
Interest Expense	-	-0.01	-0.02	-0.05	-0.03	Upgrade
Interest & Investment Income	11.15	16.73	7.07	0.3	2.97	Upgrade
Other Non Operating Income (Expenses)	-0.51	-0.74	-0.57	-0.17	-0.08	Upgrade
EBT Excluding Unusual Items	-176.21	-261.34	-334.89	-266.97	-133.15	Upgrade
Gain (Loss) on Sale of Investments	-	0.85	1.07	-0.03	0.05	Upgrade
Pretax Income	-176.21	-260.49	-333.82	-266.99	-133.1	Upgrade
Net Income	-176.21	-260.49	-333.82	-266.99	-133.1	Upgrade
Net Income to Common	-176.21	-260.49	-333.82	-266.99	-133.1	Upgrade
Shares Outstanding (Basic)	53	52	52	52	46	Upgrade
Shares Outstanding (Diluted)	53	52	52	52	46	Upgrade
Shares Change (YoY)	0.32%	0.32%	0.89%	13.22%	20.84%	Upgrade
EPS (Basic)	-3.35	-4.97	-6.39	-5.16	-2.91	Upgrade
EPS (Diluted)	-3.35	-4.97	-6.39	-5.16	-2.91	Upgrade
Free Cash Flow	-117.72	-195.61	-253.82	-245.57	-90.43	Upgrade
Free Cash Flow Per Share	-2.24	-3.73	-4.86	-4.74	-1.98	Upgrade
EBITDA	-168.14	-259.02	-337.58	-266.05	-135.53	Upgrade
D&A For EBITDA	18.71	18.3	3.8	1	0.48	Upgrade
EBIT	-186.85	-277.32	-341.38	-267.05	-136.01	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q